ABLE C competent cells

Supplier: Agilent Technologies
AGLS200171EA 344 EUR
AGLS200171 AGLS200162 AGLS200160 AGLS200161 AGLS200172 AGLS200170
ABLE C competent cells
Competent Cells
ABLE Competent Cells for toxic clones reduce copy number four to ten fold compared to the XL1-Blue strain.

  • Reduces the copy number of ColE1-derived plasmids (such as pUC and pBluescript® plasmids) four-fold
  • Decreases level of cloned protein product to increase cell viability
  • Transformation efficiency of 5×10⁶ to 2×10⁷ transformants/µg
  • Also available in an electroporation-competent version

ABLE C Competent Cells for toxic clones enhance the probability of cloning DNA encoding toxic proteins. By reducing the copy number of ColE1-derived plasmids, the ABLE C strain decreases the levels of cloned gene products and enhances the probability of propagating a toxic clone.

The ABLE C Competent Cells provide a viable alternative to commonly used cloning vectors with high copy numbers. Positive clones observed on initial screening of lambda libraries can be excised or re-cloned into any convenient vector and can be introduced into ABLE C strains.

ABLE K Competent Cells for toxic clones enhance the probability of cloning DNA encoding toxic proteins. By reducing the copy number of ColE1-derived plasmids, the ABLE K strain decreases the levels of cloned gene products and enhances the probability of propagating a toxic clone.

ABLE K Competent Cells provide a viable alternative to commonly used cloning vectors with high copy numbers. Positive clones observed on initial screening of lambda libraries can be excised or re-cloned into any convenient vector and can be introduced into ABLE K strains.

Caution: For research use only. Not for use in diagnostic procedures.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR